UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 4.266

Sortiert nach

Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome

Gut, 2022-03, Vol.71 (3), p.544

2022

Volltextzugriff (PDF)

Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19

Gut, 2021-04, Vol.70 (4), p.733

2021

Volltextzugriff (PDF)

Current and Past Infections of HBV Do Not Increase Mortality in Patients With COVID‐19

Hepatology (Baltimore, Md.), 2021-10, Vol.74 (4), p.1750-1765

2021

Volltextzugriff (PDF)

SARS-CoV-2 non-structural protein 6 triggers NLRP3-dependent pyroptosis by targeting ATP6AP1

Cell death and differentiation, 2022-06, Vol.29 (6), p.1240-1254

2022

Volltextzugriff (PDF)

Treatment intensification with stepwise addition of prandial insulin aspart boluses compared with full basal-bolus therapy (FullSTEP Study): a randomised, treat-to-target clinical trial

The lancet. Diabetes & endocrinology, 2014, Vol.2 (1), p.30-37

2014

Volltextzugriff (PDF)

Impact of the Use of Oral Antiviral Agents on the Risk of Hospitalization in Community Coronavirus Disease 2019 Patients (COVID-19)

Clinical infectious diseases, 2023-02, Vol.76 (3), p.e26-e33

2023

Volltextzugriff (PDF)

Minimal Risk of Drug-Induced Liver Injury With Molnupiravir and Ritonavir-Boosted Nirmatrelvir

Gastroenterology (New York, N.Y. 1943), 2023-01, Vol.164 (1), p.151-153

2023

Volltextzugriff (PDF)

Significantly Lower Case-fatality Ratio of Coronavirus Disease 2019 (COVID-19) than Severe Acute Respiratory Syndrome (SARS) in Hong Kong-A Territory-Wide Cohort Study

Clinical infectious diseases, 2021-05, Vol.72 (10), p.e466-e475

2021

Volltextzugriff (PDF)

Would chronic mucus hypersecretion affect the clinical response to medications of COPD patients?

Respirology (Carlton, Vic.), 2022-12, Vol.27 (12), p.1006-1007

2022

Volltextzugriff (PDF)

Effect of short‐course exercise training on the frequency of exacerbations and physical activity in patients with COPD: A randomized controlled trial

Respirology (Carlton, Vic.), 2021-01, Vol.26 (1), p.72-79

2021

Volltextzugriff (PDF)

Interleukin-38 ameliorates poly(I:C) induced lung inflammation: therapeutic implications in respiratory viral infections

Cell death & disease, 2021-01, Vol.12 (1), p.53-18, Article 53

2021

Volltextzugriff (PDF)

Incidence of Viral Rebound After Treatment With Nirmatrelvir-Ritonavir and Molnupiravir

JAMA network open, 2022-12, Vol.5 (12), p.e2245086-e2245086

2022

Volltextzugriff (PDF)

Many patients labelled as having mild asthma do not have well‐controlled asthma

Respirology (Carlton, Vic.), 2018-04, Vol.23 (4), p.348-349

2018

Volltextzugriff (PDF)

Epidemiology, clinical spectrum, viral kinetics and impact of COVID‐19 in the Asia‐Pacific region

Respirology (Carlton, Vic.), 2021-04, Vol.26 (4), p.322-333

2021

Volltextzugriff (PDF)

Sensitisation to recombinant Aspergillus fumigatus allergens and clinical outcomes in COPD

The European respiratory journal, 2023-01, Vol.61 (1), p.2200507

2023

Volltextzugriff (PDF)

Molecular detection of respiratory pathogens and typing of human rhinovirus of adults hospitalized for exacerbation of asthma and chronic obstructive pulmonary disease

Respiratory research, 2019-09, Vol.20 (1), p.210-9, Article 210

2019

Volltextzugriff (PDF)

Environmental fungal sensitisation associates with poorer clinical outcomes in COPD

The European respiratory journal, 2020-08, Vol.56 (2), p.2000418

2020

Volltextzugriff (PDF)

Reply to Hoffmann and Wolf

Clinical infectious diseases, 2021-10, Vol.73 (7), p.e1782-e1783

2021

Volltextzugriff (PDF)

Interferon response and profiling of interferon response genes in peripheral blood of vaccine-naive COVID-19 patients

Frontiers in immunology, 2024-01, Vol.14, p.1315602-1315602

2024

Volltextzugriff (PDF)

Characterization of METRNβ as a novel biomarker of Coronavirus disease 2019 severity and prognosis

Frontiers in immunology, 2023-01, Vol.14, p.1111920-1111920

2023

Volltextzugriff (PDF)

Respiratory admissions before and during the COVID‐19 pandemic with mediation analysis of air pollutants, mask‐wearing and influenza rates

Respirology (Carlton, Vic.), 2023-01, Vol.28 (1), p.47-55

2023

Volltextzugriff (PDF)

Profiling of SARS-CoV-2 Subgenomic RNAs in Clinical Specimens

Microbiology spectrum, 2022-04, Vol.10 (2), p.e0018222-e0018222

2022

Volltextzugriff (PDF)

Risks of AKI and Major Adverse Clinical Outcomes in Patients with Severe Acute Respiratory Syndrome or Coronavirus Disease 2019

Journal of the American Society of Nephrology, 2021-04, Vol.32 (4), p.961-971

2021

Volltextzugriff (PDF)

Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials

Vaccine, 2019-04, Vol.37 (18), p.2482-2493

2019

Volltextzugriff (PDF)

1 – 25 von 4.266

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.846)
Mit Volltextzugriff
(3.944)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.818)
Life Sciences & Biomedicine
(1.983)
Humans
(1.323)
Male
(683)
Female
(678)
Animals
(671)
Physical Sciences
(510)
Biological And Medical Sciences
(480)
Technology
(413)
Middle Aged
(359)
Adult
(345)
Medical Sciences
(313)
Mice
(302)
Science & Technology - Other Topics
(292)
Aged
(286)
Biochemistry & Molecular Biology
(268)
Chemistry
(268)
Multidisciplinary Sciences
(232)
Fundamental And Applied Biological Sciences. Psychology
(211)
Oncology
(200)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome

Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19

Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19

Current and Past Infections of HBV Do Not Increase Mortality in Patients With COVID‐19

SARS-CoV-2 non-structural protein 6 triggers NLRP3-dependent pyroptosis by targeting ATP6AP1

Treatment intensification with stepwise addition of prandial insulin aspart boluses compared with full basal-bolus therapy (FullSTEP Study): a randomised, treat-to-target clinical trial

Impact of the Use of Oral Antiviral Agents on the Risk of Hospitalization in Community Coronavirus Disease 2019 Patients (COVID-19)

Minimal Risk of Drug-Induced Liver Injury With Molnupiravir and Ritonavir-Boosted Nirmatrelvir

Significantly Lower Case-fatality Ratio of Coronavirus Disease 2019 (COVID-19) than Severe Acute Respiratory Syndrome (SARS) in Hong Kong-A Territory-Wide Cohort Study

Would chronic mucus hypersecretion affect the clinical response to medications of COPD patients?

Effect of short‐course exercise training on the frequency of exacerbations and physical activity in patients with COPD: A randomized controlled trial

Interleukin-38 ameliorates poly(I:C) induced lung inflammation: therapeutic implications in respiratory viral infections

Incidence of Viral Rebound After Treatment With Nirmatrelvir-Ritonavir and Molnupiravir

Many patients labelled as having mild asthma do not have well‐controlled asthma

Epidemiology, clinical spectrum, viral kinetics and impact of COVID‐19 in the Asia‐Pacific region

Sensitisation to recombinant Aspergillus fumigatus allergens and clinical outcomes in COPD

Molecular detection of respiratory pathogens and typing of human rhinovirus of adults hospitalized for exacerbation of asthma and chronic obstructive pulmonary disease

Environmental fungal sensitisation associates with poorer clinical outcomes in COPD

Reply to Hoffmann and Wolf

Interferon response and profiling of interferon response genes in peripheral blood of vaccine-naive COVID-19 patients

Characterization of METRNβ as a novel biomarker of Coronavirus disease 2019 severity and prognosis

Respiratory admissions before and during the COVID‐19 pandemic with mediation analysis of air pollutants, mask‐wearing and influenza rates

Profiling of SARS-CoV-2 Subgenomic RNAs in Clinical Specimens

Risks of AKI and Major Adverse Clinical Outcomes in Patients with Severe Acute Respiratory Syndrome or Coronavirus Disease 2019

Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials

Suchergebnisse filtern